• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析对肾病患者苯唑西林、氨苄西林和四环素生理处置的影响。

The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.

作者信息

Ruedy J

出版信息

Can Med Assoc J. 1966 Feb 5;94(6):257-61.

PMID:5903164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1935278/
Abstract

Seven patients with acute or chronic renal failure who were receiving intermittent peritoneal dialysis and who required parenteral oxacillin, ampicillin or tetracycline were studied to determine the disposition of these antibiotics in severe renal disease and the effects of peritoneal dialysis. While severe renal impairment markedly prolongs persistence in the serum of ampicillin and tetracycline, there is little effect on oxacillin. Whereas required doses of ampicillin and tetracycline are lower in the presence of severe renal disease, oxacillin should be given in doses equivalent to those used for patients with normal renal function. Peritoneal dialysis does not alter these dosage requirements.Four patients receiving ampicillin or tetracycline in the infusing solution during peritoneal dialysis were studied to determine the amount of systemic absorption. Local prophylaxis alone is not achieved with this method of administration, since small amounts of both antibiotics are absorbed systemically from the infusing solution. The serum concentration of tetracycline attained is inadequate for treatment of systemic infections but is probably significant, with repeated use in intermittent dialysis, in causing adverse effects. Tetracycline should be abandoned in the local prophylaxis of peritonitis during peritoneal dialysis.

摘要

对7例接受间歇性腹膜透析且需要胃肠外使用苯唑西林、氨苄西林或四环素的急性或慢性肾衰竭患者进行了研究,以确定这些抗生素在严重肾脏疾病中的处置情况以及腹膜透析的影响。虽然严重肾功能损害显著延长了氨苄西林和四环素在血清中的持续时间,但对苯唑西林影响不大。严重肾脏疾病患者所需的氨苄西林和四环素剂量较低,而苯唑西林的给药剂量应与肾功能正常患者使用的剂量相当。腹膜透析不会改变这些剂量要求。对4例在腹膜透析期间于输注溶液中接受氨苄西林或四环素的患者进行了研究,以确定全身吸收量。采用这种给药方法不能仅实现局部预防,因为两种抗生素均有少量从输注溶液中被全身吸收。所达到的四环素血清浓度不足以治疗全身感染,但在间歇性透析中反复使用时,可能会显著导致不良反应。在腹膜透析期间局部预防腹膜炎时应放弃使用四环素。

相似文献

1
The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.腹膜透析对肾病患者苯唑西林、氨苄西林和四环素生理处置的影响。
Can Med Assoc J. 1966 Feb 5;94(6):257-61.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
[Development of peritoneal dialysis at Rijeka Clinical Hospital Center].[里耶卡临床医院中心腹膜透析的发展]
Acta Med Croatica. 2004;58(3):215-20.
4
[Therapeutic suggestions on antibiotic therapy in patients with and without renal function disorders].
Dtsch Gesundheitsw. 1969 Mar 13;24(11):481-6.
5
Peritoneal dialysis in the neonatal period: outcome data.
J Perinatol. 1993 Jan-Feb;13(1):59-64.
6
Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.在接受持续性非卧床腹膜透析和持续性循环腹膜透析的终末期肾病患者中,使用大剂量腹腔内氨基糖苷类药物治疗腹膜炎。
Adv Perit Dial. 2000;16:280-4.
7
[Elimination of antibiotics and sulfonamides from the human organism during renal insufficiency and the therapeutic consequences].
Int Z Klin Pharmakol Ther Toxikol. 1969 Apr;2(2):154-64.
8
Failed peritoneal dialysis in a dehydrated nephrotic child, in acute renal failure: a case report.
Niger Postgrad Med J. 2002 Sep;9(3):158-62.
9
An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.使用尼日利亚产腹膜透析液对腹膜透析和血液透析的有效性及益处进行的分析。
Afr J Med Med Sci. 2005 Sep;34(3):227-33.
10
[Kinetics of ampicillin, oxacillin and carbenicillin after a short intravenous infusion in man].[人短期静脉输注氨苄西林、苯唑西林和羧苄西林后的动力学]
Arzneimittelforschung. 1976;26(9):1709-15.

引用本文的文献

1
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.体外试验中,苯唑西林和万古霉素对耐甲氧西林金黄色葡萄球菌的敏感株无杀菌拮抗或协同作用。
Antimicrob Agents Chemother. 2010 Feb;54(2):773-7. doi: 10.1128/AAC.00348-09. Epub 2009 Nov 23.
2
Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.肾功能受损、血液透析及腹膜透析对美洛西林药代动力学的影响。
Antimicrob Agents Chemother. 1980 Jul;18(1):81-7. doi: 10.1128/AAC.18.1.81.
3
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.药物动力学特性的差异:对肾衰竭患者选用特定药物的意义,特别强调抗生素和β-肾上腺素能受体阻滞剂。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003.
4
A clinical trial of cephaloridine.头孢噻啶的一项临床试验。
Can Med Assoc J. 1966 Jun 25;94(26):1343-8.
5
Absorption of antibiotics during peritoneal dialysis in patients with renal failure.肾衰竭患者腹膜透析期间抗生素的吸收情况。
J Clin Pathol. 1968 Jan;21(1):88-92. doi: 10.1136/jcp.21.1.88.
6
Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.奥硝唑在肾功能不全患者中的药代动力学;血液透析和腹膜透析的影响。
Br J Clin Pharmacol. 1985 Feb;19(2):211-7. doi: 10.1111/j.1365-2125.1985.tb02633.x.
7
Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.接受腹膜透析患者的药物治疗。临床药代动力学考量
Clin Pharmacokinet. 1985 Sep-Oct;10(5):404-25. doi: 10.2165/00003088-198510050-00003.
8
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.
9
Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.腹膜透析对血清妥布霉素和克林霉素水平的影响。
Antimicrob Agents Chemother. 1975 Nov;8(5):574-80. doi: 10.1128/AAC.8.5.574.
10
Comparative penetration of amikacin, gentamicin, and penicillin g into exudate fluid in experimental sterile peritonitis.阿米卡星、庆大霉素和青霉素G在实验性无菌性腹膜炎中渗入渗出液的比较
Antimicrob Agents Chemother. 1977 Jan;11(1):110-3. doi: 10.1128/AAC.11.1.110.

本文引用的文献

1
Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.急性肾衰竭患者血液中抗生素的持续存在。I. 四环素和金霉素
J Clin Invest. 1959 Sep;38(9):1487-97. doi: 10.1172/JCI103927.
2
Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.急性肾衰竭患者血液中抗生素的持续存在。II. 重症肾病或肝硬化患者血液中的氯霉素及其代谢产物。
J Clin Invest. 1959 Sep;38(9):1498-508. doi: 10.1172/JCI103928.
3
Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.急性肾衰竭患者血液中抗生素的持续存在情况。III. 青霉素、链霉素、红霉素和卡那霉素。
J Clin Invest. 1959 Sep;38(9):1509-19. doi: 10.1172/JCI103929.
4
PERITONEAL DIALYSIS. CURRENT STATUS AND FUTURE APPLICATIONS.腹膜透析。现状与未来应用。
Pediatr Clin North Am. 1964 Aug;11:593-609. doi: 10.1016/s0031-3955(16)31585-1.
5
PERITONEAL TRANSPORT OF ANTIBIOTICS IN MAN.人体中抗生素的腹膜转运
N Engl J Med. 1965 Apr 1;272:666-9. doi: 10.1056/NEJM196504012721304.
6
Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.去甲金霉素;一种新的四环素类抗生素,具有更强且更持久的抗菌活性。
N Engl J Med. 1958 Nov 20;259(21):999-1005. doi: 10.1056/NEJM195811202592102.